CH200183A - Process for preparing the alpha-phenyl-n-valerate of diethylaminoethanol. - Google Patents
Process for preparing the alpha-phenyl-n-valerate of diethylaminoethanol.Info
- Publication number
- CH200183A CH200183A CH200183DA CH200183A CH 200183 A CH200183 A CH 200183A CH 200183D A CH200183D A CH 200183DA CH 200183 A CH200183 A CH 200183A
- Authority
- CH
- Switzerland
- Prior art keywords
- phenyl
- alpha
- ester
- acid
- mixture
- Prior art date
Links
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- -1 di-ethylamino Chemical group 0.000 claims description 5
- 239000008096 xylene Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 231100000331 toxic Toxicity 0.000 claims description 3
- 230000002588 toxic effect Effects 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 2
- 229910052753 mercury Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- ROXZSHRRSBRWIW-UHFFFAOYSA-N 1-chloro-n,n-diethylethanamine Chemical compound CCN(CC)C(C)Cl ROXZSHRRSBRWIW-UHFFFAOYSA-N 0.000 claims 1
- RTRZIWZZYGDMFE-UHFFFAOYSA-N 1-chloro-n,n-diethylethanamine;hydron;chloride Chemical compound Cl.CCN(CC)C(C)Cl RTRZIWZZYGDMFE-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- RLMOTNBFJWWVFS-UHFFFAOYSA-N chloroethane;n-ethylethanamine Chemical compound CCCl.CCNCC RLMOTNBFJWWVFS-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Procédé<B>de</B> préparation de Palpha-phényl-n-valérate du diéthylarainoéthanol. Il a été constaté par la demanderesse que les esters d'acides alpha-phényl-,%liphgtiques et d'amino-alcools-n-aliphatiques-N-disubsti- tués possèdent des propriétés spasmolytiques marquées, tout en ayant une action toxique particulièrement faible.
Par acides alp-ha,-phényl-aliphatiques", il faut entendre des acides aliphatiques satu rés ou non-saturés, qui portent un groupe, phényle sur<B>le</B> carbone voisin du groupe carboxyle et qui ont la structure générale re présentée par la formule,.
EMI0001.0011
(formule dans laquelle R est un radical by- drocarburé saturé ou non-saturé), c'est-à-dire l'acide 2-phényl-propionique -et ses homo logues supérieurs et les composés non- saturés correspondants.
La, présente invention a, pour objet un procédé de préparation de l'un de<I>cm esters,</I> <B>à</B> savair l'alpha-phényl-n-valérate du diéthyl- a,mino-éth,auo,l, qui possède une valeur théra peutique int6rm-sante, et par conséquent trouve une application en thérapeutique.
Ce procédé est caraGt6ris6 en ce que l'on fait réagir l'acide alpha-phényl-n-valérique ou un de ses sels avec un composé livrant le reste<B>-</B> C'H# <B>-<I>N =</I></B> (C'll')-.
Voici trois exemples d'exécution pratique de ce procédé, dans lesquels on fait réagir res pectivement: un sel alcalin de l'acide alpha-phényl-n- valôrique avec le diéthylamineehloréthane; l'acide %lpha-phényl-n-va-lérique avec le -diéthylamino-chlo,réthane; et le-dit acide avec le diéthylamino-éthanol. <I>Exemple</I><B>1:
</B> Dans un ballon de<B>500</B> cm' <B>à</B> trois cals, muni d'un agitateur mécanique et d'un condenseur<B>à</B> reflux, on introduit <B>0J</B> mül-gr d'alpha-phényl-n-valérate de po tassium, sec et<B>75</B> cm' de benzène sec, et en- suite une solution de<B>0,1</B> mol-gr de diéthyl- amino--chloréthane CI-CH'.CH2.N(C2H5)2 dans<B>50</B> cm' de benzène sec. On chauffe le mélange pendant 4 heures sous refluxen agi tant.
Les sels minéraux sont séparés par la vage avec de l'eau, et le produit est ensuite rectifié par distillation. L'amino-ester formé:
EMI0002.0007
bout de 140<B>' à</B> 144<B> C</B> sous une pression de <B>3</B> mm de mercure; c'est un nouveau corps pos sédant des propriétés spasmolytiques mar quées, tout en ayant une action toxique parti- culiè-ement faible. Son chlorhydrate fond<B>à</B> <B>109 0</B> C.
<I>Exemple</I> 2: On mélange<B>0,1</B> mol-gr d'a cide alpha-phényl-n-valérique#, <B>0,1</B> mol-gr du chlorhydrate de diéthyl-amino-chloréthane, <B>0,15</B> mol-gr de carbonate de potassium anhydre avec<B>25</B> cm' d'acétone. Onchauffe le mélange sous un condenoeur <B>à</B> reflux pendant <B>10</B> heures en agitant.
Après refroidissement, on le filtre, et l'acétone retenue dans le fil trat est éliminée par évaporation.<B>Le</B> résidu est repris dans de l'éther; la solution éthérée est lavée avec une solution de carbonate de sodium<B>à 10 %</B> et est ensuite extraite par une solution d'acide chlorhydrique<B>à 5 %.</B> Cette solution de chlorhydrate, est rendue alcaline par du carbonate de sodium et est extraite avec de l'éther. Après évaporation de l'éther et rectification, on obtient l'alpha-phényl-n- valérate de diéthylaminoëthanol précédem ment décrit.
<I>Exemple<B>3:</B></I> On mélange<B>0,1</B> mol-gr d'a cide alpha-phényl-n-valérique, <B>0,10</B> mol-gr de diéthylaminoéthanol, <B>80</B> cm' de xylène et <B>0,13</B> mol-gr d'acide benzènesulfonique dans un ballon<B>à</B> trois cols, de<B>500</B> cm', muni d'un agitateur mécanique, d'un entonnoir et d'une colonne de rectification.
On fait bouillir le mélange pendant 4 heures tout en ajoutant une quantité de xylène égaJe <B>à</B> celle qui dis tille (environ<B>500</B> cm' de xylène). Le xylène resté dans le ballon est lavé avec une solu tion de carbonate de sodium<B>à</B> 10%, pour en- lever l'acide alpha -phényl-n-valérique qui n'a pas réagi,
puis on en extrait l'amino-ester par quelques lavages avec de l'acide oblorhydri- que <B>à 5%.</B> L'amino-ester mis en liberté par le carbonate de sodium est extrait avec<B>de</B> l'éther et la solution éthérée est lavée avec de l'eau, séchée et rectifiée.
Comme<B>on</B> le voit des trois exemples ci- dessus, ce sont toujours les mêmes radicaux des corps de départ qui se trouvent dans le produit fini.
Process <B> for </B> the preparation of alpha-phenyl-n-valerate of diethylarainoethanol. It has been observed by the Applicant that the esters of alpha-phenyl- acids,% liphgtiques and of amino-aliphatic-n-aliphatic-N-disubstituted alcohols possess marked spasmolytic properties, while having a particularly weak toxic action. .
By alp-ha, -phenyl-aliphatic acids "is meant saturated or unsaturated aliphatic acids which bear a phenyl group on <B> the </B> carbon adjacent to the carboxyl group and which have the structure general re presented by the formula ,.
EMI0001.0011
(formula in which R is a saturated or unsaturated hydrocarbon radical), that is to say 2-phenyl-propionic acid - and its higher homologues and the corresponding unsaturated compounds.
The present invention relates to a process for the preparation of one of <I> cm esters, </I> <B> to </B> savair the alpha-phenyl-n-valerate of diethyl-a, mino-eth, auo, l, which has an int6rm-health therapeutic value, and therefore finds application in therapy.
This process is characterized by reacting alpha-phenyl-n-valeric acid or a salt thereof with a compound yielding the remainder <B> - </B> C'H # <B> - < I> N = </I> </B> (C'll ') -.
Here are three examples of the practical execution of this process, in which the following are reacted respectively: an alkali salt of alpha-phenyl-n-valoric acid with diethylamine chloroethane; % alpha-phenyl-n-va-leric acid with -diethylamino-chlo, rethane; and said acid with diethylaminoethanol. <I>Example</I> <B> 1:
</B> In a <B> 500 </B> cm '<B> </B> three-callus flask, fitted with a mechanical stirrer and a reflux <B> </B> condenser, <B> 0J </B> mül-gr of potassium alpha-phenyl-n-valerate, dry and <B> 75 </B> cm 'of dry benzene are introduced, and then a solution of < B> 0.1 </B> mol-gr of CI-CH'.CH2.N (C2H5) 2 diethylaminochloroethane in <B> 50 </B> cm 'of dry benzene. The mixture is heated for 4 hours under reflux while stirring.
The mineral salts are separated by the vage with water, and the product is then rectified by distillation. The amino ester formed:
EMI0002.0007
end of 140 <B> 'at </B> 144 <B> C </B> under a pressure of <B> 3 </B> mm of mercury; it is a new body with attractive spasmolytic properties, while having a particularly weak toxic action. Its hydrochloride melts <B> at </B> <B> 109 0 </B> C.
<I> Example </I> 2: Mixing <B> 0.1 </B> mol-gr of alpha-phenyl-n-valeric acid #, <B> 0.1 </B> mol- gr of diethyl-amino-chloroethane hydrochloride, <B> 0.15 </B> mol-gr of anhydrous potassium carbonate with <B> 25 </B> cm 'of acetone. The mixture is heated under a reflux condenser for <B> 10 </B> hours while stirring.
After cooling, it is filtered, and the acetone retained in the trat wire is removed by evaporation. <B> The </B> residue is taken up in ether; the ethereal solution is washed with <B> 10% </B> sodium carbonate solution and is then extracted with <B> 5% hydrochloric acid solution. </B> This hydrochloride solution is made alkaline with sodium carbonate and is extracted with ether. After evaporation of the ether and rectification, the previously described diethylaminoethanol alpha-phenyl-n-valerate is obtained.
<I>Example<B>3:</B> </I> Mix <B> 0.1 </B> mol-gr of alpha-phenyl-n-valeric acid, <B> 0.10 </B> mol-gr of diethylaminoethanol, <B> 80 </B> cm 'of xylene and <B> 0.13 </B> mol-gr of benzenesulfonic acid in a <B> to </ B flask > three necks, <B> 500 </B> cm ', fitted with a mechanical stirrer, a funnel and a rectification column.
The mixture is boiled for 4 hours while adding an amount of xylene equal to <B> to </B> that which disilutes (approximately <B> 500 </B> cm 'of xylene). The xylene remaining in the flask is washed with a <B> </B> 10% sodium carbonate solution to remove the unreacted alpha -phenyl-n-valeric acid,
then the amino ester is extracted therefrom by washing several times with <B> 5% hydrofluoric acid. </B> The amino ester released by sodium carbonate is extracted with <B> of the ether and the ethereal solution is washed with water, dried and rectified.
As can be seen from the three examples above, it is always the same radicals of the starting bodies that are found in the finished product.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB200183X | 1936-10-16 | ||
| GB81236X | 1936-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH200183A true CH200183A (en) | 1938-09-30 |
Family
ID=26241958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH200183D CH200183A (en) | 1936-10-16 | 1937-10-15 | Process for preparing the alpha-phenyl-n-valerate of diethylaminoethanol. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH200183A (en) |
-
1937
- 1937-10-15 CH CH200183D patent/CH200183A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH200183A (en) | Process for preparing the alpha-phenyl-n-valerate of diethylaminoethanol. | |
| CH200184A (en) | Process for preparing the alpha-phenyl-n-valerate of diethylaminoethanol. | |
| BE834298R (en) | METHYLAMINE ACTIVE DERIVATIVES, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THE PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES AND COMPOSITIONS | |
| CH299369A (en) | Process for preparing a new product with an amber odor. | |
| BE558542A (en) | ||
| CH294337A (en) | A process for the preparation of an optically active amino-propanediol. | |
| US1792717A (en) | Process of making safrol derivatives such as vanillin and isochavibetol | |
| CH288986A (en) | Process for preparing an aromatic acylamidodiol, nitrated in the nucleus. | |
| CH400185A (en) | Process for the preparation of α-carboxylated lactones | |
| Mills et al. | CCCXLIV.—Symmetrical substitution derivatives of trimethylene dibromide and pentamethylene dibromide | |
| BE444578A (en) | Process for obtaining substitutes for peppery spices | |
| CH289889A (en) | Process for preparing an aromatic acylamidodiol. | |
| CH289890A (en) | A process for the preparation of an aromatic acylamidodiol. | |
| BE347323A (en) | ||
| CH306901A (en) | Process for the preparation of a new chemical compound having antispasmodic activity. | |
| CH396031A (en) | Process for the preparation of new hydrazine derivatives | |
| CH395971A (en) | Process for preparing a novel ester of beta cycloalkyl propionic acid | |
| CH353749A (en) | Process for the preparation of amino ester-ethers | |
| CH370093A (en) | Process for the preparation of diamino-caproic acid derivatives | |
| BE628519A (en) | ||
| CH281899A (en) | Process for the preparation of a new derivative of ethyl α-ethylacetoacetate. | |
| CH312041A (en) | Process for preparing a succinimide. | |
| CH191846A (en) | Process for obtaining a thiazol compound. | |
| CH268051A (en) | Process for preparing 1-methyl-4-piperazine-N, N-diethyl-carboxamide. | |
| BE831390A (en) | PROCESS FOR THE PREPARATION OF 3- (1-BENZYLCYCLOHEPTYL) OXY-N, N-DIMETHYLPROPYLAMINE ACID FUMARATE |